Notice
Submission of manuscript to scientific journal
Registration date : 2020.11.20
NovMetaPharma and NovMetaHealth submitted their papers to top-level scientific journals according to the following as scheduled.
NovMetaPharma
- Paper Topic: Chronic kidney disease
- Submission Date: September 22, 2020
- Paper Contents: A study on the prevention and treatment of chronic kidney disease of C01, which brings all three pathological causes of chronic kidney disease (cell death, inflammation, fibrosis), as well as the verification of the correlation between endogenous C01 and molecular targets in clinical samples.
- Future Plan: Develop treatment for chronic kidney disease.
- Market Summary: The market for chronic kidney disease treatment is worth about 15 trillion won/year, which mainly consists of the sales of popular treatment treatments such as hypertension treatment and diuretics due to the absence of direct treatment, making the development of new treatments urgent.
NovMetaHealth
- Paper Topic: Acute pancreatitis
- Submission Date: September 18, 2020
- Paper Contents: Study results on the efficacy of the prevention and treatment of acute pancreatitis
- Future Plan: Develop the treatment of acute pancreatitis
- Market Summary: Market Research Future, an overseas market research firm, estimates that the global market for acute pancreatitis will reach 5 trillion won. This market size is expected to increase by an average of 3.5% per year by 2023, but therapeutic drugs to improve acute pancreatitis have not been developed at present, and only infusion therapy is used to for the conservative treatment of complications.